- Home
- Publications
- Publication Search
- Publication Details
Title
Disulfiram: a novel repurposed drug for cancer therapy
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-11
DOI
10.1007/s00280-020-04216-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
- (2020) Ting Sun et al. Cell Communication and Signaling
- Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties
- (2020) Yuya Terashima et al. Nature Communications
- Targeting the NPL4 Adaptor of p97/VCP Segregase by Disulfiram as an Emerging Cancer Vulnerability Evokes Replication Stress and DNA Damage while Silencing the ATR Pathway
- (2020) Dusana Majera et al. Cells
- Disulfiram potentiates docetaxel cytotoxicity in breast cancer cells through enhanced ROS and autophagy
- (2020) K. Laxmi Swetha et al. Pharmacological Reports
- Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma
- (2020) Hirofumi Yoshino et al. PLoS One
- Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model
- (2020) Brittney S. Harrington et al. Cancers
- A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
- (2019) Jiayi Huang et al. JOURNAL OF NEURO-ONCOLOGY
- Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma
- (2019) Priyanka Shah O’Brien et al. Journal of Clinical Medicine
- Disulfiram’s anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase
- (2019) Zdenek Skrott et al. ONCOGENE
- Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
- (2019) Silvia Schmidtova et al. Cancers
- Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel
- (2019) Xiao Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Repurposing disulfiram for cancer therapy via targeted nanotechnology through enhanced tumor mass penetration and disassembly
- (2018) Huacheng He et al. Acta Biomaterialia
- Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes
- (2018) Saeed Hassani et al. BIOMEDICINE & PHARMACOTHERAPY
- Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer
- (2018) Xi Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma
- (2018) Jiayi Huang et al. JOURNAL OF NEURO-ONCOLOGY
- Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death
- (2018) Young Min Park et al. PLoS One
- Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
- (2017) Ranjan Bista et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells
- (2017) Zhipeng Wang et al. Nanomedicine-Nanotechnology Biology and Medicine
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
- (2017) Zdenek Skrott et al. NATURE
- Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2
- (2017) Bing Xu et al. Cell Death & Disease
- Cell cycle specific radiosensitisation by the disulfiram and copper complex
- (2017) Mathias Tesson et al. Oncotarget
- Docosahexaenoic acid and disulfiram act in concert to kill cancer cells: a mutual enhancement of their anticancer actions
- (2017) Yang Jiao et al. Oncotarget
- Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies
- (2017) Jay Arora et al. Oncotarget
- Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma
- (2016) X. Lun et al. CLINICAL CANCER RESEARCH
- A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy
- (2016) Jiayi Huang et al. JOURNAL OF NEURO-ONCOLOGY
- Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models
- (2016) Manman Deng et al. Oncotarget
- Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells
- (2016) Xinwei Liu et al. Oncotarget
- Targeting copper in cancer therapy: ‘Copper That Cancer’
- (2015) Delphine Denoyer et al. Metallomics
- Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
- (2015) Jennifer L. Allensworth et al. Molecular Oncology
- A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
- (2015) H. Nechushtan et al. ONCOLOGIST
- Concise Review: Bullseye: Targeting Cancer Stem Cells to Improve the Treatment of Gliomas by Repurposing Disulfiram
- (2015) Joanna Triscott et al. STEM CELLS
- Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo
- (2015) Hongbiao Huang et al. Oncotarget
- Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide
- (2015) Joanna Triscott et al. Oncotarget
- A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
- (2015) Richard E. Kast et al. Oncotarget
- Liposome encapsulated Disulfiram inhibits NFκB pathway and targets breast cancer stem cells in vitro and in vivo
- (2015) Peng Liu et al. Oncotarget
- Blocking the formation of radiation–induced breast cancer stem cells
- (2015) Yangyang Wang et al. Oncotarget
- Copper Signaling Axis as a Target for Prostate Cancer Therapeutics
- (2014) R. Safi et al. CANCER RESEARCH
- On the interaction of copper(ii) with disulfiram
- (2014) David J. Lewis et al. CHEMICAL COMMUNICATIONS
- Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition
- (2014) Jie Zha et al. Journal of Translational Medicine
- Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
- (2014) Tetsuhiro Chiba et al. PLoS One
- Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells
- (2013) P Liu et al. BRITISH JOURNAL OF CANCER
- The Role of Copper in Disulfiram-Induced Toxicity and Radiosensitization of Cancer Cells
- (2013) C. Rae et al. JOURNAL OF NUCLEAR MEDICINE
- Redirecting Apoptosis to Aponecrosis Induces Selective Cytotoxicity to Pancreatic Cancer Cells through Increased ROS, Decline in ATP Levels, and VDAC
- (2013) R. D. Dinnen et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer
- (2013) M T Schweizer et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
- (2012) P Liu et al. BRITISH JOURNAL OF CANCER
- Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies
- (2012) Concetta Conticello et al. INTERNATIONAL JOURNAL OF CANCER
- Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
- (2011) N C Yip et al. BRITISH JOURNAL OF CANCER
- Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
- (2011) Boris Cvek DRUG DISCOVERY TODAY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now